BTTX

Better Therapeutics (BTTX)

Better Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BTTX

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/14	22:38	Business Wire	Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/11	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/05	23:25	Business Wire	Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/04	23:25	Business Wire	Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/04	22:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/01	20:08	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/20	23:25	Business Wire	Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/13	06:28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/06	23:43	Business Wire	Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/06	23:02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/26	06:30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/24	07:22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/17	23:28	Business Wire	Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/10	21:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/09	06:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/05	04:00	Business Wire	Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/02	21:45	Business Wire	Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/29	11:23	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/28	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/22	07:21	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/14	07:24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/14	07:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/08	10:09	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/01	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/28	21:45	Business Wire	Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/21	07:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/14	21:00	Business Wire	Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award	NASDAQ:BTTX	Better Therapeutics Inc